Stock Market News for April 1, 2026
758 news published.
Major M&A and corporate moves
Keurig Dr Pepper (KDP) closed a landmark deal to acquire JDE Peet's and named Rafael Oliveira as CEO of the combined global coffee business—consolidating brands and supply chains in consumer staples. (transaction details)
OneStream (OS) announced the completion of its acquisition by Hg for $6.4 billion, a large private-equity exit that removes a public software asset from the market and reshapes enterprise-software M&A comps. (deal note)
Gilead Sciences (GILD) extended its tender offer to acquire Arcellx, signaling persistence to close a strategically important cell-therapy tuck-in that would expand Gilead’s oncology footprint; investors should watch revised timelines and any financing or regulatory updates. (tender extension)
Deals, financing and capital markets
Micron (MU) announced the expiration of cash tender offers for certain senior notes—an active liability-management move that trims interest costs and signals capital-allocation priorities.
American Assets Trust (AAT) increased its revolving line of credit to $500 million and extended the maturity under its amended credit agreement, a liquidity boost that supports development pipelines and REIT flexibility. (credit agreement)
Stitch Fix (SFIX) resumed its share repurchase program, returning to buybacks as a tool to support the stock and signal confidence in free-cash-flow leverage—watch repurchase pace and offset against inventory dynamics.
UMH Properties (UMH) issued a first-quarter 2026 operations update—keep an eye on occupancy, rent-growth trends and any guidance shifts for residential REITs. (operations update)
AI, cloud, cyber and enterprise moves
IBM (IBM) expanded its FedRAMP portfolio with authorization for 11 software solutions, including watsonx, broadening government cloud opportunities and enterprise AI sales cycles.
Sharon AI (SHAZ) signed a 5‑year, $1.25B AI cloud infrastructure deal, underscoring durable hyperscaler and enterprise spending on AI-native capacity. (announcement)
Shutterstock (SSTK) launched a licensed-content integration with ChatGPT, another sign of platform monetization as AI tools embed licensed assets into enterprise workflows. (product launch)
Regulatory openings and market access
eToro (ETOR) said it now offers cryptoasset investing in New York, opening a major U.S. retail market and signaling continued regulatory thaw for crypto platforms.
Legal, litigation and corporate actions
Churchill Downs Incorporated (CHDN) celebrated a district-court victory in its suit against the Horseracing Integrity and Safety Authority; the ruling reduces a regulatory overhang and clarifies legal risk for racing operators. (statement)
Big contracts, transport and infrastructure
Target Hospitality (TH) secured a $550M+ multi-year contract with a top-five hyperscaler to support data-center development—strengthening its workforce-housing pipeline tied to cloud buildouts. (contract note)
Intel will repurchase a 49% equity interest in its Ireland fab joint venture, reshaping capital commitments and control over a strategic European manufacturing footprint—watch foundry strategy implications. (details)
Space, defense and advanced tech
AeroVironment (AVAV) was selected to deliver ISR services to the U.S. Navy with its JUMP 20‑X and advanced payload integrations—another defense win validating unmanned payload commercialization. (award note)
EV deliveries and China auto momentum
Li Auto (LI) issued its March delivery update, keeping a close watch on demand and supply-chain resilience in China’s EV market. (details)
XPeng (XPEV) and NIO (NIO) released March and Q1 delivery figures—data that will influence near-term sentiment on growth, inventory and promotional intensity among Chinese EV OEMs. (XPeng | NIO)
Stellantis (STLA) reported U.S. first-quarter sales up 4% year-over-year, a modest but meaningful sign of recovery in light-vehicle demand.
Consumer-facing earnings & results
Tilray Brands (TLRY) posted record Q3 fiscal 2026 results—$207M net revenue and $55M gross profit—suggesting margin recovery across cannabis and beverage segments. (earnings)
Lamb Weston (LW) raised its sales and EBITDA outlook after third-quarter results, a positive read-through for foodservice recovery and input-cost leverage. (report)
The Estée Lauder Companies (EL) said it has fully established its “One ELC” operating model and reached a milestone in its profit-recovery and growth plan—an operational inflection that investors should view as central to margin improvement and brand portfolio execution. (company update)
Biotech, medtech and trial news
Eli Lilly (LLY) secured a major regulatory win as the FDA approved Foundayo™ (orforglipron), the first GLP‑1 pill cleared for weight loss that can be taken any time—this materially expands oral GLP‑1 market dynamics and could reshape competitive positioning. (approval details)
Cogent Biosciences (COGT) submitted a New Drug Application for bezuclastinib in GIST—an NDA that could reprice the oncology franchise if accepted. (NDA submission)
Alto Neuroscience (ANRO) reported topline data from a Phase 2 proof-of-concept study of ALTO-101 and highlighted pipeline advancements—investors will parse effect size for next-phase design and partnering appeal. (topline results)
Tempus (TEM) and Medtronic reported ALERT trial results where AI-driven EHR notifications improved treatment for valvular heart disease—evidence that clinical AI can shift care pathways and payer adoption. (trial results)
Adagene (ADAG) reported full-year 2025 financial results and provided a corporate update—bio investors should note cash runway, R&D cadence and partnering moves that affect valuation. (results)
Energy, sustainability and resources
Largo (LGO) reported fourth-quarter and full-year 2025 results showing U.S. tariffs’ impact on Q4 sales, while flotation test results for copper–platinum group metals point to stronger operating momentum heading into 2026. (results)
New Height Energy / TCBI announced a transformative acquisition of producing oil & gas assets in the Midland Basin, a move that can materially boost cash flow and reserves—monitor capex needs and commodity-price sensitivity. (transaction)
Sempra (SRE) highlighted that regional natural-gas storage helped Southern Californians avoid more than $120 million in energy costs during Winter Storm Fern, underscoring the value of storage and resilience investments. (analysis)
Westwater Resources (WWR) provided a commercial update—battery‑materials and lithium-focused investors should watch contract flow and offtake progress for near-term revenue visibility. (update)
Ero Copper (ERO) will release first-quarter 2026 operating and financial results on May 4, 2026—mark the date for a potential production and cost update that affects copper supply expectations. (release notice)
Selected operational updates and product moves
- Merit Medical (MMSI) acquired View Point Medical, expanding the Merit therapeutic oncology portfolio and recurring-consumables revenue. (acquisition details)
What to watch next
Monitor Gilead’s extended tender for Arcellx for revised closing windows and any financing or antitrust developments that could shift biotech M&A comps.
Watch capital-allocation moves: Micron’s tender, American Assets Trust’s credit, and Stitch Fix’s buyback restart for signals on buyback pacing versus reinvestment.
In biotech, parse Alto’s Phase 2 topline and Cogent’s NDA for effect size and regulatory-readiness cues that shape partnering and valuation.
Keep an eye on consumer and retail execution after Estée Lauder’s One ELC milestone, and note the Ero Copper Q1 release on May 4 for near-term commodity and operational clarity.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement